What Is NAD+? Coenzyme Research Overview
NAD+ is a coenzyme, not a peptide: the redox carrier and enzyme substrate at the center of cellular-energy research. Here's what the literature describes, from NADH to sirtuins to the salvage pathway.
If you've searched "what is NAD+" or "NAD+ meaning," the short answer is that NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. It is not a peptide, though it is often listed alongside research peptides. NAD+ is supplied here strictly as a research-grade reference standard, and this overview summarizes what the published literature describes: its redox chemistry, the enzymes that consume it, how cells recycle it, and how it relates to MOTS-c and SS-31 research. It describes the molecule, not how anyone should use it.
What is NAD+? The coenzyme behind cellular redox
NAD+ is built from two nucleotides joined through their phosphate groups. One half carries an adenine base; the other carries a nicotinamide ring, the reactive part of the molecule. Put another way, NAD+ is nicotinamide mononucleotide (NMN) and adenosine monophosphate (AMP) linked by a pyrophosphate bridge. The "+" refers to the positive charge on the nicotinamide nitrogen in the oxidized form.
Its best-known job is carrying electrons. Many enzymes, most of them dehydrogenases, use NAD+ to accept electrons from one molecule and pass them on, linking the breakdown of sugars and fats to the mitochondrial machinery that makes ATP.
NAD+ vs NADH: oxidation or reduction?
NAD+ and NADH are the same molecule in two redox states. NAD+ is the oxidized form and NADH is the reduced form. When a dehydrogenase removes a hydride ion (two electrons and a proton) from its substrate and hands it to NAD+, the coenzyme is reduced to NADH. So NAD+ to NADH is a reduction, and NADH back to NAD+ is an oxidation.
This cycle runs through central metabolism. Glycolysis, the pyruvate dehydrogenase step and the citric acid (TCA) cycle all reduce NAD+ to NADH. NADH then donates its electrons to complex I of the mitochondrial electron transport chain, which regenerates NAD+ and helps build the proton gradient used for ATP synthesis. The NAD+/NADH ratio is therefore a common readout of redox state in research models. A phosphorylated relative, the NADP+/NADPH pair, runs a largely separate set of reactions, including biosynthesis and the regeneration of reduced glutathione.
What does NAD+ do beyond redox? Sirtuins, PARPs and CD38
Redox reactions interconvert NAD+ and NADH without using the coenzyme up. A second group of enzymes does consume it: they cleave NAD+, use its ADP-ribose portion, and release nicotinamide.
Sirtuins
Sirtuins are NAD+-dependent deacylases. Mammals have seven (SIRT1 to SIRT7), spread across the nucleus, cytoplasm and mitochondria. Each deacylation removes an acetyl or other acyl group from a target protein and consumes one molecule of NAD+, which ties sirtuin activity directly to NAD+ availability. In cell and animal models, that coupling makes sirtuins a central topic in metabolic-regulation and aging-model research.
PARPs
Poly(ADP-ribose) polymerases, PARP1 above all, are activated by DNA strand breaks. They use NAD+ to build chains of ADP-ribose on proteins at the damage site, a signal that recruits DNA-repair machinery. Extensive DNA damage in cell models can drive PARP activity high enough to deplete cellular NAD+ noticeably, which is why PARPs feature in DNA-repair and genotoxic-stress research.
CD38
CD38 is a membrane-associated NAD+-degrading enzyme (an NADase), expressed prominently on immune cells and studied as one of the major routes of NAD+ breakdown in mammalian tissue. Rodent studies have reported higher CD38 expression in older tissue, which places it in aging-model research alongside sirtuins and PARPs.
The salvage pathway: how cells recycle NAD+
Because the consuming enzymes release nicotinamide, cells keep their NAD+ supply going mainly by recycling it. In the salvage pathway, the enzyme NAMPT converts nicotinamide into NMN, the rate-limiting step, and NMNAT enzymes then convert NMN into NAD+. Nicotinamide riboside (NR) joins the same route after being phosphorylated to NMN. Cells can also build NAD+ from tryptophan (the de novo, or kynurenine, pathway) and from nicotinic acid (the Preiss-Handler pathway), but salvage is regarded as the main route in most mammalian tissues.
A related enzyme, NNMT, methylates nicotinamide and so diverts it away from salvage. 5-Amino-1MQ is studied as an NNMT inhibitor in this part of the literature.
What is NAD+ used for in research?
As a reference standard, NAD+ appears in cell and animal-model research on:
- Redox balance and the NAD+/NADH ratio
- Mitochondrial respiration and electron transport at complex I
- Sirtuin activity and protein deacetylation
- PARP activation and DNA-repair signaling
- CD38 and NAD+ degradation in aging models
- Salvage-pathway enzymes such as NAMPT and NMNAT
NAD+ vs NMN, NR and other molecules
The "NAD+ vs NMN" and "NAD+ or NMN" questions come up constantly, and the neutral answer is that the two occupy different positions in the same pathway. NMN is a precursor, one enzymatic step upstream of NAD+ in the salvage pathway, and NR sits one step further back. NAD+ is the coenzyme itself: the molecule the dehydrogenases, sirtuins, PARPs and CD38 actually use. A research design picks the point in the pathway it wants to probe. Eon Research does not supply NMN or NR; the NAD+ reference standard is the coenzyme itself.
- NAD+ vs NR: nicotinamide riboside is converted to NMN, then to NAD+.
- NAD+ vs glutathione: glutathione is a tripeptide thiol antioxidant kept in its reduced form by NADPH, so the two meet in redox research without being interchangeable.
- NAD+ vs NAC: N-acetylcysteine is a cysteine derivative studied as a glutathione precursor, not an NAD+ precursor.
MOTS-c vs NAD+: how they relate in research
Queries like "MOTS-c vs NAD+" and "MOTS-c and NAD+" pair two very different molecules. MOTS-c is a 16-amino-acid peptide encoded in the mitochondrial genome and studied as a signaling molecule; NAD+ is a coenzyme that enzymes cycle between redox states or consume outright. They are not alternatives on any scale.
Where they meet is the AMPK pathway. MOTS-c research centers on AMPK activation in cell and animal models, and AMPK has in turn been linked in the literature to NAD+ metabolism and sirtuin activity. That gives researchers a reason to study the two side by side: MOTS-c as an upstream signal, NAD+ as the cofactor sirtuins depend on. Our what is MOTS-c overview covers the peptide itself, and the SS-31 vs MOTS-c comparison sets it against the cardiolipin-targeting peptide SS-31. The mitochondrial and energy research collection groups all three.
Handling NAD+ as a reference standard
NAD+ is supplied as a lyophilized powder in multi-vial research kits and is reconstituted with a diluent such as bacteriostatic water before assay use. The NAD+ reconstitution calculator returns concentration and aliquot volumes for each vial size, and the how to reconstitute peptides guide walks through the bench steps. Kits ship from our US facility within 48 hours with tracking, and NAD+ sits in our cognitive and neuro catalog.
Frequently asked questions
What is NAD+?
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell. It carries electrons in redox reactions as the NAD+/NADH pair and is consumed as a substrate by sirtuins, PARPs and CD38. Eon Research supplies it as a research-use-only reference standard.
Is NAD+ a peptide?
No. NAD+ is a dinucleotide, two nucleotides joined through phosphate groups, not a chain of amino acids. It is listed with research peptides because it is studied in the same mitochondrial and cellular-energy research models.
Is NAD+ to NADH an oxidation or a reduction?
A reduction. NAD+ accepts a hydride (two electrons and a proton) to become NADH. NADH is oxidized back to NAD+, for example at complex I of the electron transport chain.
What is the difference between NAD+ and NMN?
NMN (nicotinamide mononucleotide) is a precursor that NMNAT enzymes convert into NAD+ in the salvage pathway. NAD+ is the coenzyme itself. Eon Research supplies NAD+ only, not NMN.
How does MOTS-c relate to NAD+?
MOTS-c is a mitochondrial-derived peptide studied for AMPK signaling; NAD+ is a coenzyme. AMPK has been linked in the literature to NAD+ metabolism and sirtuin activity, so the two appear together in cell and animal-model research on cellular energy sensing.
What is the half-life of NAD+?
There is no single figure. Inside cells NAD+ is made and consumed continuously, and in animal-model research its turnover varies by tissue and cellular compartment. Human pharmacokinetics are outside the scope of a research-use-only overview.